Skip to content
Wednesday, 18 November 2026
Inspire.News

Unveiling truth, one story at a time

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy
Image: CNBC

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

Full story

Continue reading this story on CNBC, the publisher that reported it.

Read the full story at CNBC ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business

See all